Evidence map›Paper›PMID 12941921›Full record

ArticleJournal of virology2003

Development of pseudorabies virus strains expressing red fluorescent proteins: new tools for multisynaptic labeling applications.

Bruce W Banfield, Jessica D Kaufman, Jessica A Randall, Gary E Pickard

Abstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Viral tools for neuroscience.Nature reviews. Neuroscience · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bruce W BanfieldDepartment of Microbiology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Campus Box B175, Denver, CO 80262, USA. bruce.banfield@uchsc.edu
Jessica D Kaufman
Jessica A Randall
Gary E Pickard

Funding

5HT PRESYNAPTIC INHIBITION OF RETINAL INPUT TO THE SCNR01NS035615 · NINDS · UNIVERSITY OF NEBRASKA LINCOLN · PI PICKARD, GARY EDWARD · 1997 to 2008
$2.7M
Modulation of cell signaling pathways by alphaherpesvirus tegument componentsR01AI048626 · NIAID · UNIVERSITY OF COLORADO DENVER · PI BANFIELD, BRUCE W · 2001 to 2011
$2.5M
Retinal Neurons Afferent to the Circadian SystemR01MH062296 · NIMH · COLORADO STATE UNIVERSITY-FORT COLLINS · PI PICKARD, GARY EDWARD · 2001 to 2005
$1.6M
NIAID NIH HHS AI 48626NIAID NIH HHS R01 AI048626NIMH NIH HHS MH 62296NIMH NIH HHS R01 MH062296NINDS NIH HHS NS 35615NINDS NIH HHS R01 NS035615
6 · The paper itself

Abstract

The transsynaptic retrograde transport of the pseudorabies virus Bartha (PRV-Bartha) strain has become an important neuroanatomical tract-tracing technique. Recently, dual viral transneuronal labeling has been introduced by employing recombinant strains of PRV-Bartha engineered to express different reporter proteins. Dual viral transsynaptic tracing has the potential of becoming an extremely powerful method for defining connections of single neurons to multiple neural circuits in the brain. However, the present use of recombinant strains of PRV expressing different reporters that are driven by different promoters, inserted in different regions of the viral genome, and detected by different methods limits the potential of these recombinant virus strains as useful reagents. We previously constructed and characterized PRV152, a PRV-Bartha derivative that expresses the enhanced green fluorescent protein. The development of a strain isogenic to PRV152 and differing only in the fluorescent reporter would have great utility for dual transsynaptic tracing. In this report, we describe the construction, characterization, and application of strain PRV614, a PRV-Bartha derivative expressing a novel monomeric red fluorescent protein, mRFP1. In contrast to viruses expressing DsRed and DsRed2, PRV614 displayed robust fluorescence both in cell culture and in vivo following transsynaptic transport through autonomic circuits afferent to the eye. Transneuronal retrograde dual PRV labeling has the potential to be a powerful addition to the neuroanatomical tools for investigation of neuronal circuits; the use of strain PRV614 in combination with strain PRV152 will eliminate many of the pitfalls associated with the presently used pairs of PRV recombinants.

Indexed as

AnimalsCell LineGanglia, SpinalGreen Fluorescent ProteinsHerpesvirus 1, SuidLuminescent ProteinsRatsRed Fluorescent ProteinSuprachiasmatic NucleusSynapsesGreen Fluorescent ProteinsLuminescent ProteinsRed Fluorescent Protein

Identifiers

PMID12941921
PMCPMC224573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.